Loading clinical trials...
Loading clinical trials...
The bRIGHT EU PAS study is an observational real-world study evaluating severe tricuspid regurgitation patients treated with the Abbott TriClip™ device (bRIGHT EU Post-Approval Study).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Abbott Medical Devices
NCT07342036 · Tricuspid Valve Regurgitation, Pacemaker, and more
NCT07267117 · Heart Valve Disease, Mitral Valve (MV) Regurgitation, and more
NCT05194423 · Tricuspid Valve Regurgitation
NCT04577248 · Mitral Valve Regurgitation, Mitral Valve Stenosis, and more
NCT06700239 · Tricuspid Regurgitation Functional, Tricuspid Regurgitation, and more
Universitätsklinik Graz
Graz
Odense University Hospital
Odense
University Hospital Bonn
Bonn, North Rhine-Westphalia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions